Search

Your search keyword '"Piscopo G"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Piscopo G" Remove constraint Author: "Piscopo G"
164 results on '"Piscopo G"'

Search Results

4. Optimal cashback in a cooperative framework for peer-to-peer insurance coverages

6. Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease

11. FAECAL EVALUATION OF PDG IN A FEMALE OKAPI (Okapia Johnstoni) TO DEFINE OESTRUS CYCLE AND FERTILE WINDOW FOR REPRODUCTION PROGRAM OF CONSERVATION

12. DIETETIC AND TOXICOLOGICAL PARAMETERS EVALUATION IN AONYX CINEREUS

14. Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial

17. Quality Evaluation of Bank Credit: Empirical Evidence Using Logistic Regression Model

18. Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation

20. Myth #8: The Myth of Scale, Beyond Scale: The Quest for Quality

21. Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking

23. 2018 Compendium of Radiation-Induced Effects for Candidate Particle Accelerator Electronics

24. Practical approach to patient therapy affected by Autosomal Dominant Autosomic Polycystic Kidney Disease

30. Poster session 4: Friday 5 December 2014, 08:30-12:30Location: Poster area

32. Theatre in prison as a virtual place of knowledge creation

36. Utility of 2D-speckle tracking echocardiography in early identification of left ventricular dysfunction in antineoplastic therapy-induced cardiotoxicity

38. Late INa Inhibition with Ranolazine Blunts Doxorubicin- Induced Cardiac Dysfunction and Remodeling in Mice

39. The Tyrosine Kinase ErbB2 Inhibitor Lapatinib and the Anti- ErbB2 Antibody Trastuzumab Depress Cardiac Function Without Inducing Left Ventricular Dilation in Mice

40. Inhibition of cardiomyocytes late I-Na with ranolazine blunts anthracyclines-cardiotoxicity in experimental models in vitro and in vivo

41. ANTHRACYCLINE INDUCED CARDIOTOXICITY IN MICE IS PREVENTED BY LATE INA INHIBITION WITH RANOLAZINE, WITH IMPROVEMENT IN HEART FUNCTION, FIBROSIS, APOPTOSIS

42. Effect of inhibition of ErbB2-tyrosine kinase domain with lapatinib on cardiac dysfunction compared to the antibody trastuzumab in mice

43. The antineoplastic ErbB2-antibody 2c4 produces left ventricular dysfunction in murine hearts

46. Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction

48. Allergia alimentare in età pediatrica in Italia: prevalenza, caratteristiche cliniche e comuni approcci diagnostici

Catalog

Books, media, physical & digital resources